The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients

The treatment for chronic active antibody-mediated rejection (CAMR) remains controversial. We investigated the efficacy of rituximab (RTX) and intravenous immunoglobulin (IVIg) for CAMR. Eighteen patients with CAMR were treated with RTX (375 mg/m2) and IVIg (0.4 g/kg) for 4 days. The efficacy of RTX...

Full description

Bibliographic Details
Main Authors:	Gun Hee An, Jintak Yun, Yu Ah Hong, Marina Khvan, Byung Ha Chung, Bum Soon Choi, Cheol Whee Park, Yeong Jin Choi, Yong-Soo Kim, Chul Woo Yang
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2014/828732

Similar Items

Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection
by: Yaeni Kim, et al.
Published: (2014-06-01)

Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin
by: Tae Hyun Ban, et al.
Published: (2021-01-01)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
by: A. Razzaque Ahmed, et al.
Published: (2018-07-01)

Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA.
by: Byung Ha Chung, et al.
Published: (2015-01-01)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
by: Tae Hyun Ban, et al.
Published: (2019-12-01)

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
by: Gastón J Piñeiro, et al.
Published: (2018-10-01)

Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients.
by: Ji Won Min, et al.
Published: (2016-01-01)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
by: Caroline Pilon, et al.
Published: (2020-01-01)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
by: Yohan Park, et al.
Published: (2020-07-01)

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
by: Knight T, et al.
Published: (2017-05-01)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01)

INTRAVENOUS IMMUNOGLOBULIN ADMINISTRATION FOR DESENSITIZATION BEFORE RENAL TRANSPLANTATION AND MANAGING ANTIBODY-MEDIATED REJECTION
by: A. I. Sushkov, et al.
Published: (2011-06-01)

Rituximab use in late antibody-mediated rejection
by: S B Bansal
Published: (2016-01-01)

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.
by: Marie Matignon, et al.
Published: (2017-01-01)

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
by: Djamal Djeddi, et al.
Published: (2020-09-01)

Impact of acute kidney injury in expanded criteria deceased donors on post-transplant clinical outcomes: multicenter cohort study
by: Woo Yeong Park, et al.
Published: (2019-02-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010-07-01)

Intravenous immunoglobulin in dermatology
by: Dhar Sandipan
Published: (2009-01-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS
by: A.Yu. Shcherbina, et al.
Published: (2010-01-01)

Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients
by: Veronica Di Cristanziano, et al.
Published: (2021-08-01)

Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants
by: Chih-Yuan Lee, et al.
Published: (2016-10-01)

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients
by: Woo Yeong Park, et al.
Published: (2021-06-01)

Effect of intradialytic change in blood pressure and ultrafiltration volume on the variation in access flow measured by ultrasound dilution
by: Hoon Suk Park, et al.
Published: (2013-03-01)

Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment
by: Jong Hoon Lee, et al.
Published: (2013-12-01)

Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
by: F Ahmadi, et al.
Published: (2019-07-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
by: Kasia A. Sablik, et al.
Published: (2019-06-01)

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)

Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study.
by: Jong Hoon Lee, et al.
Published: (2018-01-01)

Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin
by: Evelyne Tarnowietzki, et al.
Published: (2020-10-01)

In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
by: Mehta Y, et al.
Published: (1996-04-01)

Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study
by: Wiwat Chancharoenthana, et al.
Published: (2021-08-01)

Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.
by: Kyoung Woon Kim, et al.
Published: (2018-01-01)

Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome
by: Min Cheol Chang, et al.
Published: (2021-01-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Intravenous immunoglobulin: Revisited – My experience
by: Sanjeev S Vaishampayan, et al.
Published: (2021-01-01)